Study links milk-producing protein to aggressive breast cancer
- Naxal threat has to be quashed with a firm hand, says Pranab, as Maoists kill 16 in Chhattisgarh ambush
- Malaysia military tracked missing plane to the west coast
- AAP defends Rs 20,000 per person dinner with Kejriwal, says it was transparent
- Bhagwat cautions RSS cadres against crossing limits for BJP
- Narendra Modi's new found love for Bihar a ploy to win votes: Nitish Kumar
The discovery that a protein which triggers milk production in women may also be responsible for making breast cancers aggressive could open up new opportunities for treatment of the most common and deadliest form of cancer among women.
Found in all breast cells, the protein ELF5 tries to activate milk production even in breast cancer cells, which does not work and then makes the cancer more aggressive, according to scientists in Australia and Britain.
"The discovery opens up new avenues for therapy and for designing new markers that can predict response to therapy," said lead author Professor Chris Ormandy from the Garvan Institute of Medical Research in Sydney.
In 2008, Ormandy's work linked ELF5 to milk production.
The latest research by Ormandy and his team, published in the journal PLOS Biology on Friday, went a step further to find the link between ELF5 and breast cancer.
"Cancer cells can't respond properly (to ELF5), so they... acquire some characteristics ... that make the disease more aggressive and more refractory (resistant) to treatment with existing therapies," Ormandy said by telephone.
Ormandy and his team grew human breast cancer tissues, genetically manipulated to contain high amounts of ELF5, in petri dishes and saw how the protein proliferated aggressively.
FINDINGS MAY HELP TARGETED THERAPY
Breast cancer is the most commonly diagnosed cancer and the top cause of cancer death among women, accounting for 23 percent of total cancer cases and 14 percent of cancer deaths in women.
To decide on treatment, doctors normally need to find out if the cancer has receptors for the hormones estrogen and progesterone, which, in the case of breast cancer patients, promote growth in their tumours.
Two-thirds of breast cancers are usually positive for estrogen receptors, which then require anti-hormonal therapies that lower estrogen levels in the patient or block estrogen from supporting the growth of the cancer.
- School kids ‘adopt’ spotted deer at Sanjay Gandhi National Park
- Jain trust gets HC caveat to ordain minor as sadhu
- Time to help Zaheer make the decision: Prasad
- BMC in a ‘tearing’ hurry as poll code kicks in
- Two men shot at in Tilak Nagar, different versions puzzle police
- Shami makes most of lively wicket
- AAP workers stage protest outside Kejriwal’s residence over ticket distribution
- BJP boycotts NDTV over news gaffe | The Indian Express
- Out of the promised 50,000 homes for the poor, not even 50 constructed in Gujarat by BJP: Kejriwal
- Kejriwal Gujarat tour: The unfamiliar politician | The Indian Express